Fortimedix has been acquired by Medtronic

Fortimedix Surgical has been successfully acquired by Medtronic (NYSE: MDT). Following the transaction, Fortimedix will operate as Medtronic Articulating Technologies.

Located at the Brightlands Chemelot Campus in Geleen, the Netherlands, Fortimedix operates a fully equipped R&D and pilot manufacturing facility that allows the seamless integration of product development and pilot manufacturing under a single roof.

Oaklins’ team in the Netherlands acted as the exclusive sell-side M&A advisor to Fortimedix in its sale to Medtronic. This transaction underscores Oaklins’ strong international track record in the medical technology sector, demonstrating their ability to unlock significant value in a rapidly evolving, innovation-driven industry. Leveraging deep sector expertise and a global network of strategic buyers, the team ensured a smooth and successful transaction process for all parties involved.

Services

Vente d'entreprise

Parties prenantes

«Our goal was to find a strategic partner for Fortimedix capable of bringing our innovative technologies into full-scale production and into operating rooms worldwide. With Medtronic, we have now found the right partner who can take the next step in delivering groundbreaking instruments to the clinic. The intensive and very pleasant collaboration with Oaklins ultimately led to this transaction. The team’s guidance and results-oriented approach proved invaluable throughout the entire process.»

Wout Bijker

CEO, Fortimedix Surgical

Contacter l'équipe de la transaction

Robert Boersma

Associé

Amsterdam, Pays-Bas
Oaklins Netherlands

Voir le profil Entrer en contact

Robbert Bon

Analyste principal

Amsterdam, Pays-Bas
Oaklins Netherlands

Voir le profil Entrer en contact

Oscar van Rijn

Analyste senior

Amsterdam, Pays-Bas
Oaklins Netherlands

Voir le profil Entrer en contact

Transactions connexes

UKAT Group has acquired Bayberry Limited

Placements Privés | Soins de la Santé

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

En apprendre plus

Medicija has acquired Saulės Šeimos Medicinos Centras

Soins de la Santé

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

En apprendre plus

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Soins de la Santé

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

En apprendre plus